Greater Glasgow and Clyde Medicines

Restrictions:

The following indications are formulary but use is restricted to specialists and according to regional protocols:

• Treatment of chemotherapy-naïve patients with stage III/IV unresectable malignant pleural mesothelioma. Use in the second line monotherapy of non-small cell lung cancer (NSCLC) is restricted to use according to regional protocol.
• Use as monotherapy for maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominently squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. For regional protocol click here.
• In combination with cisplatin as adjuvant treatment for patients with completely resected stage IIA to IIIA nonsquamous non–small-cell lung cancer (off label indication).

BNF Link